Key result
Aliskiren significantly decreased systolic BP and albumin-creatinine ratio, and attenuated renal fibrosis and inflammation markers in diabetic KK-A(y) mice.
Authors
Loading...
Hypothesis-generating for aliskiren in diabetic nephropathy; human trials required before any clinical consideration.
Furukawa et al. (2013) studied Type 2 Diabetes (in KK-A(y) mice). Aliskiren vs. Untreated (saline) was evaluated on Systolic BP, HbA1c levels, and albumin-creatinine ratio (ACR). Aliskiren significantly decreased systolic BP and albumin-creatinine ratio, and attenuated renal fibrosis and inflammation markers in diabetic KK-A(y) mice.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: